AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan
· Delayed Price · Currency is JPY 835.00
+1.00 (0.12%)
Apr 25, 2025, 3:30 PM JST
AFC-HD AMS Life Science Cash Flow Statement
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2015 - 2019 |
| Net Income | 2,264 | 1,910 | 1,545 | 1,235 | 2,157 | 1,004 | Upgrade
|
| Depreciation & Amortization | 1,240 | 1,084 | 983 | 1,005 | 648 | 508 | Upgrade
|
| Loss (Gain) From Sale of Assets | -21 | -22 | 31 | 88 | 4 | 10 | Upgrade
|
| Loss (Gain) From Sale of Investments | -19 | -47 | -44 | -10 | 3 | 32 | Upgrade
|
| Other Operating Activities | -697 | -567 | -318 | -679 | -302 | -371 | Upgrade
|
| Change in Accounts Receivable | 88 | 156 | -206 | -332 | 294 | -26 | Upgrade
|
| Change in Inventory | -801 | -1,433 | -633 | 123 | -361 | -171 | Upgrade
|
| Change in Accounts Payable | 148 | 351 | -261 | 679 | -181 | 69 | Upgrade
|
| Change in Other Net Operating Assets | 167 | 108 | -232 | -617 | 320 | 244 | Upgrade
|
| Operating Cash Flow | 2,369 | 1,540 | 865 | 1,492 | 2,582 | 1,299 | Upgrade
|
| Operating Cash Flow Growth | 1061.28% | 78.03% | -42.02% | -42.22% | 98.77% | 14.85% | Upgrade
|
| Capital Expenditures | -3,519 | -3,406 | -1,939 | -957 | -491 | -381 | Upgrade
|
| Sale of Property, Plant & Equipment | 566 | 658 | - | 3 | 3 | - | Upgrade
|
| Cash Acquisitions | 93 | 162 | -114 | 2 | 1 | - | Upgrade
|
| Investment in Securities | -388 | -188 | 254 | 388 | 147 | -76 | Upgrade
|
| Other Investing Activities | -99 | 13 | 64 | -513 | 66 | -1 | Upgrade
|
| Investing Cash Flow | -3,347 | -2,761 | -1,946 | -1,077 | -274 | -458 | Upgrade
|
| Short-Term Debt Issued | - | 1,003 | 1,093 | 2,853 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 2,172 | 1,684 | 635 | 9,500 | 700 | Upgrade
|
| Total Debt Issued | 3,077 | 3,175 | 2,777 | 3,488 | 9,500 | 700 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -1,210 | - | Upgrade
|
| Long-Term Debt Repaid | - | -487 | -380 | -1,034 | -5,581 | -830 | Upgrade
|
| Total Debt Repaid | -341 | -487 | -380 | -1,034 | -6,791 | -830 | Upgrade
|
| Net Debt Issued (Repaid) | 2,736 | 2,688 | 2,397 | 2,454 | 2,709 | -130 | Upgrade
|
| Repurchase of Common Stock | -13 | - | -79 | -288 | -152 | - | Upgrade
|
| Dividends Paid | -420 | -418 | -385 | -421 | -312 | -350 | Upgrade
|
| Other Financing Activities | -184 | -38 | -52 | -586 | -60 | -94 | Upgrade
|
| Financing Cash Flow | 2,119 | 2,232 | 1,881 | 1,159 | 2,185 | -574 | Upgrade
|
| Foreign Exchange Rate Adjustments | -53 | -2 | 3 | 16 | 3 | 3 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | -1 | 1 | - | - | -2 | Upgrade
|
| Net Cash Flow | 1,087 | 1,008 | 804 | 1,590 | 4,496 | 268 | Upgrade
|
| Free Cash Flow | -1,150 | -1,866 | -1,074 | 535 | 2,091 | 918 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -74.41% | 127.78% | 56.92% | Upgrade
|
| Free Cash Flow Margin | -3.56% | -6.18% | -4.20% | 2.33% | 9.35% | 5.80% | Upgrade
|
| Free Cash Flow Per Share | -81.72 | -132.80 | -76.43 | 37.89 | 148.62 | 65.27 | Upgrade
|
| Cash Interest Paid | 144 | 97 | 58 | 58 | 31 | 28 | Upgrade
|
| Cash Income Tax Paid | 701 | 575 | 282 | 993 | 321 | 381 | Upgrade
|
| Levered Free Cash Flow | -805.38 | -1,029 | -1,497 | -66.13 | 3,658 | 733.75 | Upgrade
|
| Unlevered Free Cash Flow | -713.5 | -965.5 | -1,461 | -30.5 | 3,689 | 753.75 | Upgrade
|
| Change in Net Working Capital | -198 | -159 | 1,528 | 711 | -2,128 | 57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.